UNSPSC 41202033: Influenza virus serological reagents

In this classification, Influenza virus serological reagents are devices used in test to identify specific Influenza virus antibodies in serum. US FDA regulates Influenza virus serological reagents under 21 CFR 866.3330 and under FDA product code GNX.

UNSPSC 41202033 Influenza virus serological reagents is a Commodity code that, based on recent state and local solicitation activity, actually frames a broader diagnostic and screening reagent market—not influenza-specific serology alone. State and local health departments, criminal justice agencies, and public health programs are buying HIV testing kits, syphilis reagents, hepatitis screening assays, and related laboratory consumables under this code. The issuing bodies include state health departments (Illinois Department of Public Health), county criminal justice supervision departments (Collin County, Texas), cities (Austin), and university health centers (University of Houston). Work ranges from one-time-use rapid test kit procurement and reagent supply contracts to integrated screening instrumentation with automated analysis and result reporting. Scope spans immunoassay screening with mass-spectrometry confirmation, electronic reporting systems, and specimen collection staffing at detention and public health facilities.

Illinois Department of Public Health appears as a repeat buyer, issuing multiple emergency and standard procurements for HIV and syphilis reagents and instrumentation since February 2026. Geographic activity concentrates in Texas and Illinois, with recent opportunities in Austin, Collin County, and Jackson County (IDPH). Representative recent opportunities include Collin County Community Supervision and Corrections Department's RFP 2026-327 for offender specimen collection and drug testing services (approximately 25,031 annual tests, $600,000 estimated value, two-year term with three optional one-year renewals, proposals due July 23, 2026); the City of Austin IFB 9100AAM1023 for rapid HIV test kits (Abbott Determine kits, 375 units annually estimated, proposals due July 17, 2026); and the Illinois Department of Public Health IFB for Hepatitis/HIV/Syphilis four-generation assay screening and instrumentation (approximately 13,200 HIV tests annually, five-year contract with up to five renewal years, proposals due March 16, 2026). IDPH also conducted emergency sole-source procurements with Abbott Laboratories for reagents and maintenance services totaling $38,079.50.